Marconato, L.; Sabattini, S.; Marisi, G.; Rossi, F.; Leone, V.F.; Casadei-Gardini, A.
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs. Cancers 2020, 12, 1272.
https://doi.org/10.3390/cancers12051272
AMA Style
Marconato L, Sabattini S, Marisi G, Rossi F, Leone VF, Casadei-Gardini A.
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs. Cancers. 2020; 12(5):1272.
https://doi.org/10.3390/cancers12051272
Chicago/Turabian Style
Marconato, Laura, Silvia Sabattini, Giorgia Marisi, Federica Rossi, Vito Ferdinando Leone, and Andrea Casadei-Gardini.
2020. "Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs" Cancers 12, no. 5: 1272.
https://doi.org/10.3390/cancers12051272
APA Style
Marconato, L., Sabattini, S., Marisi, G., Rossi, F., Leone, V. F., & Casadei-Gardini, A.
(2020). Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs. Cancers, 12(5), 1272.
https://doi.org/10.3390/cancers12051272